Print

Protalix Biotherapeutics, Inc. (PLX) To Present At The 32nd Annual J.P. Morgan Healthcare Conference  
1/7/2014 9:40:49 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CARMIEL, Israel, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), announced today that Dr. David Aviezer, the Company's President and Chief Executive Officer, will present at the 32nd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2014 at 12:00 PM, Pacific Time. The conference will be held at the Westin St. Francis Union Square Hotel in San Francisco on January 13-16, 2014. A live webcast of the presentation will be available at www.protalix.com on the event calendar page. A replay will be archived and available after the conclusion of the presentation for 90 days.

Help employers find you! Check out all the jobs and post your resume.

//-->